Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results

Míreanna comhchosúla

• Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results
  de réir: Shapiro, Amy D., et al.
  Foilsithe / Cruthaithe: (2019)
• Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
  de réir: Shapiro, Amy D., et al.
  Foilsithe / Cruthaithe: (2022)
• Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors
  de réir: Amy D. Shapiro, et al.
  Foilsithe / Cruthaithe: (2022)
• A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A
  de réir: Hermann Eichler, et al.
  Foilsithe / Cruthaithe: (2018)
• Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data
  de réir: Eichler, Hermann, et al.
  Foilsithe / Cruthaithe: (2018)